홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Dimethylformamide → N-tert-butyl-5-(1-(2-cyano-1-cyclopropylethyl)-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine-7-carboxamide

HRID 1853053
인쇄

반응식

HRID 1853053 반응식
[C:1]([CH2:3][CH:4]([N:8]1[CH:12]=[C:11]([C:13]2[N:18]3[CH:19]=[CH:20][N:21]=[C:17]3[CH:16]=[C:15]([C:22](O)=[O:23])[N:14]=2)[CH:10]=[N:9]1)[CH:5]1[CH2:7][CH2:6]1)#[N:2].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN(C=O)C.[CH3:54][C:55]([NH2:58])([CH3:57])[CH3:56].C(N(C(C)C)CC)(C)C>CCOC(C)=O>[C:55]([NH:58][C:22]([C:15]1[N:14]=[C:13]([C:11]2[CH:10]=[N:9][N:8]([CH:4]([CH:5]3[CH2:6][CH2:7]3)[CH2:3][C:1]#[N:2])[CH:12]=2)[N:18]2[CH:19]=[CH:20][N:21]=[C:17]2[CH:16]=1)=[O:23])([CH3:57])([CH3:56])[CH3:54]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 6228DimethylformamideHCID 6385Tert-ButylamineHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 674585015-(1-(2-cyano-1-cyclopropylethyl)-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine-7-carboxylic acid

생성물 1

HCID 67457616
N-tert-butyl-5-(1-(2-cyano-1-cyclopropylethyl)-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine-7-carboxamide
수율 13%

시약·촉매·용매 1

HCID 8857Ethyl Acetate용매

실험 절차

In a 2 mL flask, 5-(1-(2-cyano-1-cyclopropylethyl)-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine-7-carboxylic acid (6.5 mg, 0.020 mmol) and HATU (9.2 mg, 0.024 mmol) were dissolved in DMF (101 μL, 0.020 mmol). After 5 minutes, 2-methylpropan-2-amine (4.4 mg, 0.061 mmol) and diisopropylethylamine (11 μL, 0.061 mmol) were added and the reaction mixture stirred at ambient temperature for 45 minutes. The reaction mixture was diluted in EtOAc and washed with water, saturated sodium bicarbonate, water and brine. The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The crude material was purified by reverse phase HPLC using a gradient of 40-100% acetonitrile/water to afford N-tert-butyl-5-(1-(2-cyano-1-cyclopropylethyl)-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidine-7-carboxamide (1.0 mg, 0.0026 mmol, 13% yield). MS (apci) m/z=378.3 (M+H).

후처리

  1. washwashed with water, saturated sodium bicarbonate, water and brine
  2. dry with materialThe organic layer was dried over MgSO4
  3. filtrationfiltered
  4. concentrationconcentrated in vacuo
  5. customThe crude material was purified by reverse phase HPLC

출처 및 근거

ORD 기록
ord-2c5b3d4ac8374be389a1637dfe8cfbb8
출처 데이터셋
uspto-grants-2015_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08962596B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트